DDH1 Limited's (ASX:DDH) Stock's On An Uptrend: Are Strong Financials Guiding The Market?




  • In Business
  • 2022-12-04 23:15:27Z
  • By Simply Wall St.
 

Most readers would already be aware that DDH1's (ASX:DDH) stock increased significantly by 9.6% over the past month. Since the market usually pay for a company's long-term fundamentals, we decided to study the company's key performance indicators to see if they could be influencing the market. Specifically, we decided to study DDH1's ROE in this article.

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. Put another way, it reveals the company's success at turning shareholder investments into profits.

Check out our latest analysis for DDH1

How Do You Calculate Return On Equity?

ROE can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for DDH1 is:

10% = AU$36m ÷ AU$342m (Based on the trailing twelve months to June 2022).

The 'return' is the profit over the last twelve months. That means that for every A$1 worth of shareholders' equity, the company generated A$0.10 in profit.

What Is The Relationship Between ROE And Earnings Growth?

We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.

DDH1's Earnings Growth And 10% ROE

To start with, DDH1's ROE looks acceptable. Even so, when compared with the average industry ROE of 16%, we aren't very excited. That being the case, the significant five-year 31% net income growth reported by DDH1 comes as a pleasant surprise. Therefore, there could be other causes behind this growth. Such as - high earnings retention or an efficient management in place. Bear in mind, the company does have a respectable ROE. It is just that the industry ROE is higher. So this also does lend some color to the high earnings growth seen by the company.

Next, on comparing DDH1's net income growth with the industry, we found that the company's reported growth is similar to the industry average growth rate of 33% in the same period.

Earnings growth is an important metric to consider when valuing a stock. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). This then helps them determine if the stock is placed for a bright or bleak future. If you're wondering about DDH1's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.

Is DDH1 Making Efficient Use Of Its Profits?

DDH1's ' three-year median payout ratio is on the lower side at 24% implying that it is retaining a higher percentage (76%) of its profits. So it seems like the management is reinvesting profits heavily to grow its business and this reflects in its earnings growth number.

While DDH1 has seen growth in its earnings, it only recently started to pay a dividend. It is most likely that the company decided to impress new and existing shareholders with a dividend. Upon studying the latest analysts' consensus data, we found that the company's future payout ratio is expected to rise to 41% over the next three years. Regardless, the future ROE for DDH1 is speculated to rise to 16% despite the anticipated increase in the payout ratio. There could probably be other factors that could be driving the future growth in the ROE.

Summary

In total, we are pretty happy with DDH1's performance. Specifically, we like that it has been reinvesting a high portion of its profits at a moderate rate of return, resulting in earnings expansion. Having said that, the company's earnings growth is expected to slow down, as forecasted in the current analyst estimates. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

A Look At The Intrinsic Value Of CVS Group plc (LON:CVSG)
A Look At The Intrinsic Value Of CVS Group plc (LON:CVSG)

Does the February share price for CVS Group plc ( LON:CVSG ) reflect what it's really worth? Today, we will estimate...

Ithaca Energy plc
Ithaca Energy plc's (LON:ITH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Ithaca Energy (LON:ITH) has had a rough three months with its share price down 22%. However, stock prices are usually...

Healthia Limited
Healthia Limited's (ASX:HLA) Intrinsic Value Is Potentially 41% Above Its Share Price

In this article we are going to estimate the intrinsic value of Healthia Limited ( ASX:HLA ) by taking the expected...

There Is A Reason Kretam Holdings Berhad
There Is A Reason Kretam Holdings Berhad's (KLSE:KRETAM) Price Is Undemanding

With a price-to-earnings (or "P/E") ratio of 8.8x Kretam Holdings Berhad ( KLSE:KRETAM ) may be sending bullish signals...

Is Weakness In Dr. Martens plc (LON:DOCS) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Is Weakness In Dr. Martens plc (LON:DOCS) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dr. Martens (LON:DOCS) has had a rough three months with its share price down 42%. However, a closer look at its sound...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business